Global Biopharmaceuticals Contract Manufacturing Market Outlook , 2030

2024

Global Biopharmaceuticals Contract Manufacturing Market Outlook , 2030

Name: Global Biopharmaceuticals Contract Manufacturing Market Outlook , 2030
Brand: Bonafide Research
SKU: 95001081
Price: 3450 USD
Availability: InStock
Rating: 5 (19.55 reviews)

The Global Biopharmaceuticals Contract Manufacturing Market is expected to grow to $119.9 billion by 2030, driven by stringent regulatory standards and increased demand for contrac

Bonafide Trust
21-06-2024
Pages : 104
Figures : 79
Tables : 120
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global biopharmaceuticals contract manufacturing market is a complex ecosystem where pharmaceutical and biotechnology companies outsource the production of their drug substances and drug products to specialized contract manufacturing organizations (CMOs). This market has witnessed significant growth in recent years, driven by factors such as increasing R&D investments, the complexity of biologics manufacturing, and the need for specialized expertise. CMOs offer a range of services, including process development, clinical manufacturing, commercial manufacturing, and aseptic filling. The market is characterized by a dynamic interplay of technological advancements, regulatory compliance, and global supply chain considerations. The global landscape of biopharmaceuticals contract manufacturing is characterized by a diverse range of CMOs with varying levels of expertise and capabilities. Leading CMOs often possess advanced technologies and extensive experience in handling complex biologics, such as monoclonal antibodies and vaccines. These companies invest heavily in research and development to stay at the forefront of manufacturing innovations. In contrast, smaller CMOs may specialize in specific product types or therapeutic areas, offering niche services. The geographical distribution of CMOs is also a key factor. he global distribution of the biopharmaceuticals contract manufacturing industry is uneven, with certain regions, such as North America, Europe, and Asia Pacific, having a more mature and developed market compared to other parts of the world. The United States and Western Europe are home to many leading CMOs with advanced technologies and extensive experience. Asia Pacific, particularly China and India, is emerging as a major player in the contract manufacturing landscape, offering cost-competitive services and a growing talent pool. Emerging markets in Latin America, Africa, and the Middle East are still in the early stages of developing their contract manufacturing capabilities.

According to the research report, “Global Biopharmaceuticals Contract Manufacturing Market Outlook, 2030” published by Bonafide Research, the market is anticipated to cross US$ 119900 million by 2030 increasing from US$ 85920 million by 2023. The global biopharmaceuticals contract manufacturing market operates within a highly regulated environment. Regulatory authorities in different countries impose stringent quality, safety, and efficacy standards for drug manufacturing. Compliance with Good Manufacturing Practices (GMP) and other relevant regulations is crucial for CMOs to operate successfully. Additionally, obtaining certifications and approvals for specific drug products or manufacturing processes can be time-consuming and costly. The market is characterized by a high degree of intellectual property (IP) protection, with stringent confidentiality agreements in place to safeguard sensitive information. Opportunities for growth in the biopharmaceuticals contract manufacturing market lie in emerging markets with growing healthcare expenditure and a rising middle class. These regions offer untapped potential for CMOs to establish a presence and cater to the increasing demand for biopharmaceuticals. However, challenges such as infrastructure limitations, skilled labor shortages, and regulatory hurdles need to be addressed. Pricing in the biopharmaceuticals contract manufacturing market is complex and influenced by various factors, including drug complexity, production volume, technology transfer requirements, and the level of service provided by the CMO. The average selling price (ASP) for contract manufacturing services can vary significantly depending on the specific project. The market is characterized by a mix of long-term contracts with fixed pricing and project-based agreements with variable pricing models.
Market Dynamics
Market Drivers
Increasing Outsourcing by Biopharmaceutical Companies: Biopharmaceutical companies are increasingly outsourcing manufacturing activities to focus on core competencies such as research and development, clinical trials, and commercialization. Contract manufacturers offer specialized expertise, flexible capacity, and cost-effective solutions, making them attractive partners for drug development and commercialization.
Growing Pipeline of Biologics and Biosimilars: The pipeline of biologics and biosimilars is expanding rapidly, driving demand for contract manufacturing services. These complex molecules require specialized manufacturing processes and stringent quality control measures. Contract manufacturers with expertise in biologics production are well-positioned to capitalize on this growth opportunity.
Regulatory Stringency and Quality Focus: The biopharmaceutical industry is subject to stringent regulatory requirements to ensure product safety and efficacy. Contract manufacturers must invest in quality management systems, advanced analytical technologies, and compliance expertise to meet regulatory standards. This focus on quality and compliance is driving the adoption of robust manufacturing processes and technologies.
Market Challenges
• Supply Chain Complexity and Risk: The supply chain for biopharmaceutical manufacturing is complex and involves multiple suppliers and intermediaries. Ensuring the secure and uninterrupted supply of raw materials, components, and packaging materials is a significant challenge. Disruptions in the supply chain can lead to production delays, increased costs, and product shortages.
•
• Talent Acquisition and Retention: The contract manufacturing industry faces a shortage of skilled labor, particularly in areas such as process development, quality control, and engineering. Attracting and retaining qualified personnel is essential for maintaining operational excellence and meeting the demands of the evolving biopharmaceutical landscape.
•
• High Capital Investment and Technological Advancements: The biopharmaceutical contract manufacturing sector requires significant capital investments in state-of-the-art facilities, equipment, and technology. Keeping up with rapid technological advancements, such as single-use systems and continuous manufacturing, can be challenging for contract manufacturers. Balancing capital expenditures with return on investment is a critical consideration.
Market Trends
Rise of Cell and Gene Therapies: The emergence of cell and gene therapies is reshaping the contract manufacturing landscape. These complex and personalized treatments require specialized manufacturing capabilities, including advanced cell culture, viral vector production, and cryopreservation. Contract manufacturers are investing heavily in developing expertise in these areas to meet the growing demand from biopharmaceutical companies.
Emphasis on Digital Transformation: The adoption of digital technologies is transforming contract manufacturing operations. Advancements in data analytics, automation, and process control are enabling manufacturers to improve efficiency, reduce costs, and enhance product quality. Real-time monitoring, predictive analytics, and supply chain visibility are becoming essential for meeting the stringent regulatory requirements of the biopharmaceutical industry.
Geographic Expansion and Regional Hubs: The global distribution of clinical trials and patient populations is driving the expansion of contract manufacturing facilities into new geographic regions. Emerging markets are becoming attractive destinations for contract manufacturing due to lower operating costs and government incentives. The formation of regional manufacturing hubs is enabling companies to serve local markets more effectively and reduce supply chain risks.
•
Segmentation Analysis
Biologics lead in the Global Biopharmaceuticals Contract Manufacturing Market due to their complex manufacturing processes and specialized expertise required for their production.
The global biopharmaceuticals contract manufacturing market is primarily segmented by product type into biologics and biosimilars. Biologics, complex molecules derived from living organisms, constitute the dominant segment, characterized by its higher complexity, specialized manufacturing processes, and premium pricing. This segment encompasses a vast array of products, including monoclonal antibodies, recombinant proteins, vaccines, and cell therapies, each with distinct manufacturing challenges and regulatory hurdles. The intricate nature of biologics demands specialized expertise, advanced technologies, and stringent quality control measures, driving the need for contract manufacturing organizations (CMOs) with robust capabilities. In contrast, biosimilars, biological products highly similar to an already approved originator biologic, offer a more cost-effective alternative. While sharing similarities with biologics in terms of manufacturing complexity, biosimilars benefit from the existence of a reference product, enabling certain process optimizations. The biosimilars segment is gaining traction due to patent expirations of blockbuster biologics and increasing healthcare cost pressures. However, demonstrating biosimilarity through rigorous analytical and clinical studies remains a critical challenge, necessitating specialized CMOs with deep regulatory and technical expertise.
Process development and expertise lead in the Global Biopharmaceuticals Contract Manufacturing Market due to the complex nature of biopharmaceutical manufacturing and the need for specialized knowledge and facilities.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global biopharmaceuticals contract manufacturing (CMO) market is segmented based on application into process development, packaging, and others. Process development is a critical segment within the global biopharmaceuticals contract manufacturing market. It encompasses a range of activities, from early-stage drug discovery and formulation to the optimization and scale-up of manufacturing processes. This segment is pivotal due to its role in translating laboratory-scale research into commercial-scale production. Contract manufacturing organizations (CMOs) specializing in process development offer expertise in upstream and downstream processing, including cell culture, purification, and formulation. Their services are indispensable for biopharmaceutical companies seeking to accelerate drug development timelines and reduce costs. As the complexity of biologic drugs increases, the demand for specialized process development capabilities has grown significantly. Moreover, the need for robust and efficient manufacturing processes to ensure product quality and consistency has propelled the importance of this segment. Process development services are particularly sought after by small and medium-sized biopharmaceutical companies that lack in-house expertise or capacity to handle complex drug development projects.

Regional Analysis
North America leads in the Flip Chip market due to its strong regulatory framework, a deep pool of skilled talent, and a well-developed infrastructure.
North America has firmly established itself as the leading region in the global biopharmaceuticals contract manufacturing (CMO) market. Several factors contribute to its dominance, including a strong regulatory framework, a deep pool of skilled talent, and a well-developed infrastructure. The region's stringent regulatory standards, such as those enforced by the U.S. Food and Drug Administration (FDA), ensure high-quality manufacturing practices and patient safety. This robust regulatory environment enhances the credibility of North American CMOs, attracting global pharmaceutical companies seeking reliable manufacturing partners. Moreover, North America boasts a rich talent pool of experienced scientists, engineers, and technicians who possess expertise in biopharmaceutical manufacturing. This skilled workforce is essential for handling complex manufacturing processes, ensuring product quality, and complying with stringent regulatory requirements. Additionally, the region's universities and research institutions foster innovation and scientific advancements, contributing to the development of cutting-edge manufacturing technologies. The well-developed infrastructure in North America, including state-of-the-art manufacturing facilities, advanced logistics networks, and access to specialized equipment, further solidifies its position as a leading CMO destination. The region's proximity to major pharmaceutical hubs and research centers facilitates collaboration and knowledge sharing, fostering a dynamic and competitive market environment. Furthermore, the presence of established contract research organizations (CROs) and regulatory consulting firms provides comprehensive support services to CMOs, enhancing their ability to meet the evolving needs of pharmaceutical companies. While North America maintains a dominant position, other regions, such as Asia-Pacific and Europe, are experiencing growth in the biopharmaceuticals CMO market. However, the region's strong regulatory framework, skilled workforce, and well-developed infrastructure continue to provide a significant competitive advantage.

Key Developments
In May 2024, AGC Biologics and BioConnection, a contract development and manufacturing organization (CDMO), announced a strategic partnership to offer integrated biopharmaceutical drug development and manufacturing services. This collaboration aims to streamline the process for companies developing new biologic drugs, from pre-clinical development to commercial manufacturing.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceuticals Contract Manufacturing Market Size 2019-2030
2.1.2 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biopharmaceuticals Contract Manufacturing Segment by Type
2.2.1 Biologics
2.2.2 Biosimilars
2.3 Biopharmaceuticals Contract Manufacturing Market Size by Type
2.3.1 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Biopharmaceuticals Contract Manufacturing Segment by Application
2.4.1 Process Development
2.4.2 Packaging
2.4.3 Others
2.5 Biopharmaceuticals Contract Manufacturing Market Size by Application
2.5.1 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 Biopharmaceuticals Contract Manufacturing Market Size by Player
3.1 Biopharmaceuticals Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Biopharmaceuticals Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Biopharmaceuticals Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceuticals Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biopharmaceuticals Contract Manufacturing by Regions
4.1 Biopharmaceuticals Contract Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
4.3 APAC Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
4.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biopharmaceuticals Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceuticals Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biopharmaceuticals Contract Manufacturing by Country (2019-2024)
7.2 Europe Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biopharmaceuticals Contract Manufacturing Market Forecast
10.1 Global Biopharmaceuticals Contract Manufacturing Forecast by Regions (2025-2030)
10.1.1 Global Biopharmaceuticals Contract Manufacturing Forecast by Regions (2025-2030)
10.1.2 Americas Biopharmaceuticals Contract Manufacturing Forecast
10.1.3 APAC Biopharmaceuticals Contract Manufacturing Forecast
10.1.4 Europe Biopharmaceuticals Contract Manufacturing Forecast
10.1.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Forecast
10.2 Americas Biopharmaceuticals Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Biopharmaceuticals Contract Manufacturing Market Forecast
10.2.2 Canada Biopharmaceuticals Contract Manufacturing Market Forecast
10.2.3 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast
10.2.4 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast
10.3 APAC Biopharmaceuticals Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.2 Japan Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.3 Korea Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.5 India Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.6 Australia Biopharmaceuticals Contract Manufacturing Market Forecast
10.4 Europe Biopharmaceuticals Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.2 France Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.3 UK Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.4 Italy Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.5 Russia Biopharmaceuticals Contract Manufacturing Market Forecast
10.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.2 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.3 Israel Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.4 Turkey Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.5 GCC Countries Biopharmaceuticals Contract Manufacturing Market Forecast
10.6 Global Biopharmaceuticals Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Biopharmaceuticals Contract Manufacturing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product Offered
11.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Lonza Group AG
11.2.1 Lonza Group AG Company Information
11.2.2 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product Offered
11.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lonza Group AG Main Business Overview
11.2.5 Lonza Group AG Latest Developments
11.3 Inno Biologics Sdn Bhd
11.3.1 Inno Biologics Sdn Bhd Company Information
11.3.2 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product Offered
11.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Inno Biologics Sdn Bhd Main Business Overview
11.3.5 Inno Biologics Sdn Bhd Latest Developments
11.4 Rentschler Biopharma
11.4.1 Rentschler Biopharma Company Information
11.4.2 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product Offered
11.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Rentschler Biopharma Main Business Overview
11.4.5 Rentschler Biopharma Latest Developments
11.5 JRS Pharma
11.5.1 JRS Pharma Company Information
11.5.2 JRS Pharma Biopharmaceuticals Contract Manufacturing Product Offered
11.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 JRS Pharma Main Business Overview
11.5.5 JRS Pharma Latest Developments
11.6 AGC Biologics
11.6.1 AGC Biologics Company Information
11.6.2 AGC Biologics Biopharmaceuticals Contract Manufacturing Product Offered
11.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AGC Biologics Main Business Overview
11.6.5 AGC Biologics Latest Developments
11.7 ProBioGen
11.7.1 ProBioGen Company Information
11.7.2 ProBioGen Biopharmaceuticals Contract Manufacturing Product Offered
11.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ProBioGen Main Business Overview
11.7.5 ProBioGen Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 Toyobo Co., Ltd.
11.9.1 Toyobo Co., Ltd. Company Information
11.9.2 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
11.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Toyobo Co., Ltd. Main Business Overview
11.9.5 Toyobo Co., Ltd. Latest Developments
11.10 Samsung Biologics
11.10.1 Samsung Biologics Company Information
11.10.2 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product Offered
11.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Samsung Biologics Main Business Overview
11.10.5 Samsung Biologics Latest Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Information
11.11.2 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product Offered
11.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Main Business Overview
11.11.5 Thermo Fisher Scientific Latest Developments
11.12 Binex Co., Ltd.
11.12.1 Binex Co., Ltd. Company Information
11.12.2 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
11.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Binex Co., Ltd. Main Business Overview
11.12.5 Binex Co., Ltd. Latest Developments
11.13 WuXi Biologics
11.13.1 WuXi Biologics Company Information
11.13.2 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product Offered
11.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 WuXi Biologics Main Business Overview
11.13.5 WuXi Biologics Latest Developments
11.14 AbbVie, Inc.
11.14.1 AbbVie, Inc. Company Information
11.14.2 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product Offered
11.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 AbbVie, Inc. Main Business Overview
11.14.5 AbbVie, Inc. Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Biopharmaceuticals Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Biologics
Table 3. Major Players of Biosimilars
Table 4. Biopharmaceuticals Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 7. Biopharmaceuticals Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 10. Global Biopharmaceuticals Contract Manufacturing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Biopharmaceuticals Contract Manufacturing Revenue Market Share by Player (2019-2024)
Table 12. Biopharmaceuticals Contract Manufacturing Key Players Head office and Products Offered
Table 13. Biopharmaceuticals Contract Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biopharmaceuticals Contract Manufacturing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Regions (2019-2024)
Table 18. Global Biopharmaceuticals Contract Manufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Biopharmaceuticals Contract Manufacturing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Biopharmaceuticals Contract Manufacturing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Biopharmaceuticals Contract Manufacturing Market Size Market Share by Country (2019-2024)
Table 22. Americas Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 24. Americas Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 26. APAC Biopharmaceuticals Contract Manufacturing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Biopharmaceuticals Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 28. APAC Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 30. APAC Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 32. Europe Biopharmaceuticals Contract Manufacturing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Biopharmaceuticals Contract Manufacturing Market Size Market Share by Country (2019-2024)
Table 34. Europe Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 36. Europe Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Biopharmaceuticals Contract Manufacturing
Table 45. Key Market Challenges & Risks of Biopharmaceuticals Contract Manufacturing
Table 46. Key Industry Trends of Biopharmaceuticals Contract Manufacturing
Table 47. Global Biopharmaceuticals Contract Manufacturing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Biopharmaceuticals Contract Manufacturing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Biopharmaceuticals Contract Manufacturing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Boehringer Ingelheim Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 52. Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product Offered
Table 53. Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Boehringer Ingelheim Main Business
Table 55. Boehringer Ingelheim Latest Developments
Table 56. Lonza Group AG Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 57. Lonza Group AG Biopharmaceuticals Contract Manufacturing Product Offered
Table 58. Lonza Group AG Main Business
Table 59. Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Lonza Group AG Latest Developments
Table 61. Inno Biologics Sdn Bhd Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 62. Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product Offered
Table 63. Inno Biologics Sdn Bhd Main Business
Table 64. Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Inno Biologics Sdn Bhd Latest Developments
Table 66. Rentschler Biopharma Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 67. Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product Offered
Table 68. Rentschler Biopharma Main Business
Table 69. Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Rentschler Biopharma Latest Developments
Table 71. JRS Pharma Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 72. JRS Pharma Biopharmaceuticals Contract Manufacturing Product Offered
Table 73. JRS Pharma Main Business
Table 74. JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. JRS Pharma Latest Developments
Table 76. AGC Biologics Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 77. AGC Biologics Biopharmaceuticals Contract Manufacturing Product Offered
Table 78. AGC Biologics Main Business
Table 79. AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. AGC Biologics Latest Developments
Table 81. ProBioGen Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 82. ProBioGen Biopharmaceuticals Contract Manufacturing Product Offered
Table 83. ProBioGen Main Business
Table 84. ProBioGen Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. ProBioGen Latest Developments
Table 86. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 87. FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product Offered
Table 88. FUJIFILM Diosynth Biotechnologies Main Business
Table 89. FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 91. Toyobo Co., Ltd. Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 92. Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
Table 93. Toyobo Co., Ltd. Main Business
Table 94. Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Toyobo Co., Ltd. Latest Developments
Table 96. Samsung Biologics Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 97. Samsung Biologics Biopharmaceuticals Contract Manufacturing Product Offered
Table 98. Samsung Biologics Main Business
Table 99. Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Samsung Biologics Latest Developments
Table 101. Thermo Fisher Scientific Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 102. Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product Offered
Table 103. Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Thermo Fisher Scientific Main Business
Table 105. Thermo Fisher Scientific Latest Developments
Table 106. Binex Co., Ltd. Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 107. Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
Table 108. Binex Co., Ltd. Main Business
Table 109. Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Binex Co., Ltd. Latest Developments
Table 111. WuXi Biologics Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 112. WuXi Biologics Biopharmaceuticals Contract Manufacturing Product Offered
Table 113. WuXi Biologics Main Business
Table 114. WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. WuXi Biologics Latest Developments
Table 116. AbbVie, Inc. Details, Company Type, Biopharmaceuticals Contract Manufacturing Area Served and Its Competitors
Table 117. AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product Offered
Table 118. AbbVie, Inc. Main Business
Table 119. AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. AbbVie, Inc. Latest Developments

List of Figures
Figure 1. Biopharmaceuticals Contract Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceuticals Contract Manufacturing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biopharmaceuticals Contract Manufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biopharmaceuticals Contract Manufacturing Sales Market Share by Country/Region (2023)
Figure 8. Biopharmaceuticals Contract Manufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type in 2023
Figure 10. Biopharmaceuticals Contract Manufacturing in Process Development
Figure 11. Global Biopharmaceuticals Contract Manufacturing Market: Process Development (2019-2024) & ($ Millions)
Figure 12. Biopharmaceuticals Contract Manufacturing in Packaging
Figure 13. Global Biopharmaceuticals Contract Manufacturing Market: Packaging (2019-2024) & ($ Millions)
Figure 14. Biopharmaceuticals Contract Manufacturing in Others
Figure 15. Global Biopharmaceuticals Contract Manufacturing Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application in 2023
Figure 17. Global Biopharmaceuticals Contract Manufacturing Revenue Market Share by Player in 2023
Figure 18. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Biopharmaceuticals Contract Manufacturing Market Size 2019-2024 ($ Millions)
Figure 20. APAC Biopharmaceuticals Contract Manufacturing Market Size 2019-2024 ($ Millions)
Figure 21. Europe Biopharmaceuticals Contract Manufacturing Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size 2019-2024 ($ Millions)
Figure 23. Americas Biopharmaceuticals Contract Manufacturing Value Market Share by Country in 2023
Figure 24. United States Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Biopharmaceuticals Contract Manufacturing Market Size Market Share by Region in 2023
Figure 29. APAC Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type in 2023
Figure 30. APAC Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application in 2023
Figure 31. China Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Biopharmaceuticals Contract Manufacturing Market Size Market Share by Country in 2023
Figure 38. Europe Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 39. Europe Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 40. Germany Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Biopharmaceuticals Contract Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 54. APAC Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 55. Europe Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 57. United States Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 58. Canada Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 61. China Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 62. Japan Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 63. Korea Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 65. India Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 66. Australia Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 67. Germany Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 68. France Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 69. UK Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 70. Italy Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 71. Russia Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 72. Spain Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 75. Israel Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Biopharmaceuticals Contract Manufacturing Market Size 2025-2030 ($ Millions)
Figure 78. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Biopharmaceuticals Contract Manufacturing Market Size Market Share Forecast by Application (2025-2030)
"

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted